International Clinical Trial: Tirzepatide in Individuals With Alcohol Use Disorder and Metabolic Alcohol-Associated Liver Disease

Geneva, July 14 -- International Clinical Trials Registry received information related to the study (NCT07046819) titled 'Tirzepatide in Individuals With Alcohol Use Disorder and Metabolic Alcohol-Associated Liver Disease' on July 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Condition: Metabolic Alcohol-associated Liver Disease Alcohol Use Disorder

Intervention: Drug: Tirzepatide

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: August 1, 2025

Target Sample Size: 120

Countries of Rec...